Cardiac Imaging: Page 245

Bracco inks Amerinet deal
By AuntMinnie.com staff writers
Bracco Diagnostics of Princeton, NJ, has been awarded a contract by group purchasing organization Amerinet.
January 25, 2006
VisualSonics licenses contrast agent
By AuntMinnie.com staff writers
Microimaging ultrasound developer VisualSonics of Toronto said that it is licensing a contrast agent for the quantification of myocardial perfusion in preclinical studies from the University of Virginia in Charlottesville, VA.
January 25, 2006
Doppler US accurate for spectrum of aortic valve measurements
By Eric Barnes
Doppler ultrasound is accurate for measuring aortic stenosis, even in the small subgroup of patients with severely reduced left ventricular ejection fraction, according to French and Canadian researchers in the Journal of the American College of Cardiology.
January 25, 2006
Guidant ditches J&J for Boston Scientific
By AuntMinnie.com staff writers
Interventional device developer Guidant has terminated its merger agreement with Johnson & Johnson and signed a merger agreement with Boston Scientific.
January 24, 2006
CardiArc receives FDA nod for SPECT unit
By AuntMinnie.com staff writers
Cardiac imaging device developer CardiArc has received Food and Drug Administration 510(k) clearance for its cardiac SPECT gamma camera.
January 24, 2006
Corindus launches U.S. office
By AuntMinnie.com staff writers
Israeli cardiac cath lab technology developer Corindus has opened a U.S. headquarters in Auburndale, MA. The facility will manage sales, marketing, and clinical affairs in the U.S., according to the Haifa-based firm.
January 18, 2006
UltraSPECT brings Xpress.cardiac to Europe
By AuntMinnie.com staff writers
Israeli nuclear medicine developer UltraSPECT has completed the first European installation of its Xpress.cardiac package.
January 17, 2006
Guidant accepts Boston Scientific's offer
By AuntMinnie.com staff writers
The board of directors of interventional device firm Guidant determined today that Boston Scientific's $80 per share acquisition offer was superior to Johnson & Johnson's current agreement to acquire the firm for $73 per share, or $24.2 billion.
January 16, 2006
Thoratec selects Burbach as CEO
Interventional firm Thoratec has named Gary Burbach as its president and CEO.
January 16, 2006
Abbott amends Boston Scientific agreement
By AuntMinnie.com staff writers
Interventional device firm Abbott Laboratories said it has amended its agreement with Boston Scientific to acquire Guidant's vascular business, which is contingent on the closing of Boston Scientific's proposed acquisition of Guidant.
January 16, 2006
Boston Scientific raises Guidant offer
By AuntMinnie.com staff writers
Boston Scientific has amended its offer to acquire interventional device firm Guidant of Indianapolis to $80 per share of Guidant common stock.
January 16, 2006
Guidant, J&J announce new purchase deal
By AuntMinnie.com staff writers
The stakes are rising in the bidding war for interventional device firm Guidant. Guidant and suitor Johnson & Johnson announced a new purchase deal on Friday that would see J&J pay $24.2 billion for Guidant.
January 15, 2006
Previous Page
Page 245 of 322
Next Page